Arcus Biosciences, Inc. (RCUS)
NYSE·Healthcare·Biotechnology
$28.55
+3.35%
Mkt Cap $3.40B
Analyst Ratings
Buy
6
Hold
2
Sell
0
Price Target (24 analysts)
$31.75
Range $22.00 – $47.00
Implied Upside
+11.2%
Consensus $31.75 vs current $28.55
NYSE·Healthcare·Biotechnology
$28.55
+3.35%
Mkt Cap $3.40B
Buy
6
Hold
2
Sell
0
Price Target (24 analysts)
$31.75
Range $22.00 – $47.00
+11.2%
Consensus $31.75 vs current $28.55